Skip to main content
Premium Trial:

Request an Annual Quote

Complete Genomics, DNAnexus Partner on Cloud-based Data Solution

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Complete Genomics and DNAnexus today announced a collaboration to provide Complete Genomics' customers access to DNAnexus' cloud-based platform for the analysis of human genomic sequencing data.

The deal provides Complete Genomics' customers access to a suite of tools, which will allow them to visualize and query multiple complete human genomes and focus on relevant findings, the two firms said in a joint statement. DNAnexus will host the Complete Genomics human genome public datasets and make them available as reference data to all of its customers.

Complete Genomics' customers were provided early access to the DNAnexus solution as part of a beta-testing program.

"As we continue to refine our genome sequencing service, we want to make sure that our customers have access to the best tools available to interpret the rich datasets that we provide," Mark Sutherland, senior vice president of business development for Complete Genomics, said in a statement. "We have worked closely with DNAnexus to ensure that its informatics platform will support out detailed sequence data and thus allow our customers to capitalize on its visualization capabilities."

Financial and other terms of the collaboration were not disclosed.

DNAnexus is a universal platform built on Amazon Web Services for analyzing and storing DNA sequencing data. In the future, DNAnexus will integrate Complete Genomics Analysis Tools functionality into DNAnexus, enabling researchers to further interrogate their data and tackle complex multi-genome comparisons, the firms said.

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.